How soon do you see weight loss with Wegovy?

The first four weeks: settling in, not sprinting

Imagine you have just collected your first Wegovy pen, tucked it in the fridge door, and taken your first injection at 0.25mg. The most common experience in week one is not dramatic weight loss — it is a quieter appetite. Many people report that the mental noise around food softens a little. Portion sizes shrink almost by accident. That early shift in hunger is real, and it does nudge the scales, but the 0.25mg starting dose is designed primarily to let your digestive system adjust without overwhelming it with side effects. Do not read early results as the ceiling.

By the end of week four, some people have lost one to two kilograms; others less. Both are normal. The NHS patient information on semaglutide is clear that treatment is a gradual process, and your prescriber will only move your dose up when they are satisfied your body is tolerating the current level. Comparing your week-four number with someone else's rarely helps.

Months two to three: where most people see the clearest shift

This is when the majority of people who do well on Wegovy start to feel it working in an unmistakable way. Your dose is likely at 1mg or climbing toward 1.7mg. Appetite suppression deepens. Gastric emptying slows more noticeably, so meals feel satisfying with less food. The combination produces a reliable calorie deficit without the white-knuckle effort of conventional dieting.

Results in this window vary considerably. Factors that shape them include how your liver processes semaglutide, the quality of the reduced-calorie pattern you have alongside treatment, activity levels, sleep, and stress. The NHS England guidance on weight-management injections emphasises that lifestyle support is part of how these medicines work best, not optional extra credit. There is a fuller look at the month-by-month picture on our page covering what to expect in the first month with Wegovy.

Months four to twelve: the titration peak and what follows

By month four most people are at or approaching the 2.4mg maintenance dose, and this is where the trial data becomes most relevant. The STEP 1 trial, which ran for 68 weeks, recorded around 15% average body-weight reduction at the 2.4mg dose. That figure is an average across a large group of adults with obesity or overweight plus at least one weight-related condition; some participants lost considerably more, others less. The trial did not run on a shortcut. Sixty-eight weeks is over a year.

If you are curious about the early signals before the dose climbs, our page on how soon you see results with Wegovy walks through what to realistically expect in those opening weeks. Weight loss often slows around the six-month mark as your body reaches a lower set point. That plateau can feel discouraging, but it is a physiological response rather than a sign that treatment has stopped working. Sustaining activity and protein intake tends to help the body continue responding. Your prescriber reviews your progress before each repeat prescription, which is the right moment to raise any concerns about the pace of change. For a detailed comparison of the timeline question from a slightly different angle, this page on how long Wegovy takes to work goes deeper into the biological mechanism.

If less than 5% of body weight has been lost after six months at the highest tolerated dose, NICE guidance suggests reviewing whether continuing is appropriate. This is a clinical judgement, not an automatic stop, your prescriber weighs the whole picture. For context on how treatment is accessed and what it costs privately, the Wegovy cost page sets out what a transparent private prescription typically involves.

A note on what affects individual timelines

No two people respond identically, and that is not a disclaimer, it reflects genuine biology. Starting weight matters: a higher starting BMI often means faster early absolute loss, even if the percentage is similar. Metabolic health, thyroid function, medications that affect weight, and how consistently you inject on the same day each week all play into the rate. Injecting a day late or skipping a week resets the steady-state blood level of semaglutide and can blunt the effect temporarily.

Side effects also shape the early timeline. Nausea, the most commonly reported effect, can suppress appetite further in some people and reduce it in others who find eating less comfortable. If nausea is interfering with adequate nutrition, that is worth discussing with your prescriber rather than pushing through in silence. Our Wegovy overview page covers the full side-effect picture alongside the evidence on results, and if you want a focused answer to the question of how quickly you see weight loss with Wegovy, that dedicated page breaks down the numbers by stage of treatment. If you are weighing Wegovy against other options, the treatment overview sets out what is currently licensed in the UK.

These are prescription medicines, and the timeline you experience should be guided by a clinician who knows your health history. If you would like to explore whether Wegovy is appropriate for you, starting a free consultation connects you with a GPhC-registered prescriber who reviews your case the same day.